. 2020 Aug 11;42(1):799–806. doi: 10.1080/0886022X.2020.1803085

Table 4.

Laboratory data before the prescription of phosphate binders, stratified according to the presence or absence of a PPI.

	LC			FCH			SFOH
	Without PPI (n = 9)	With PPI (n = 10)	p-value	Without PPI (n = 7)	With PPI (n = 20)	p-value	Without PPI (n = 7)	With PPI (n = 18)	p-value
Hemoglobin (g/dl)	11.2 ± 0.5	11.6 ± 0.9	0.300^a	11.2 ± 0.8	11.0 ± 0.9	0.713^a	11.2 ± 0.7	11.1 ± 0.7	0.553^a
Albumin (g/dl)	3.6 ± 0.3	3.6 ± 0.3	0.928^a	3.9 (3.7–3.9)	3.6 (3.4–3.7)	0.127^b	3.8 ± 0.2	3.5 ± 0.2	0.006^a
Urea nitrogen (mg/dl)	78 ± 11	69 ± 11	0.079^a	68 ± 9	62 ± 13	0.259^a	72 ± 15	70 ± 14	0.766^a
Creatinine (mg/dl)	12.0 ± 2.6	10.1 ± 2.1	0.098^a	12.3 ± 2.8	12.2 ± 2.7	0.905^a	12.2 (12.0–15.0)	10.7 (9.6–11.5)	0.065^b
Calcium (mg/dl)	9.1 (8.2–9.7)	8.6 (8.3–8.9)	0.462^b	8.8 (8.7–9.6)	8.9 (8.7–9.3)	0.698^b	8.5 ± 0.6	8.8 ± 0.6	0.296^a
Phosphate (mg/dl)	6.7 ± 0.9	6.3 ± 1.0	0.341^a	6.4 ± 0.8	6.8 ± 1.2	0.432^a	6.6 ± 0.4	6.7 ± 0.7	0.550^a
Parathyroid hormone (pg/ml)	253 ± 101	281 ± 171	0.665^a	182 ± 90	250 ± 136	0.238^a	426 (305–545)	257 (169–359)	0.053^b
Phosphate, average (mg/dl)	6.1 ± 0.7	5.7 ± 0.8	0.330^a	5.7 (5.4–5.8)	6.0 (5.7–6.4)	0.056^b	6.2 ± 0.4	6.2 ± 0.6	0.894^a

Uncorrected serum calcium levels are shown. The phosphate average means the average of pre-dialysis serum phosphate levels during the 3 months before the prescription of the phosphate binder.

^aUnpaired t-test.

^bMann–Whitney rank-sum test.